Bimonthly internal assesment
BIMONTHLY INTERNAL ASSESSMENT FOR MONTH OF NOVEMBER
Question 1:
1) "55 year old male patient came with the complaints of
Chest pain since 3 days
Abdominal distension since 3 days
Abdominal pain since 3 days and decreased urine output since 3days and not passed stools since 3 days
Pain in the epigastric region:
Cardiac : Inferion wall MI
Biliary: cholecystitis, cholangitis
Pancreatitis
Vascular :abdominal aortic aneurysm
GI :gastritis, early appendicitis
2) Decreased urine output-pre renal Aki secondary to volume loss(oliguric)
3rd space loss due to pancreatitis
Sepsis induced aki
3)abdominal distention with constipation and nausea secondary to paralytic ileus
4) sob may be due to metabolic acidosis or lung involvement as pt is chronic smoker (? Copd)
https://photos.app.goo.gl/jDcfft4XgUU9x5Aq8
Increased vascular permeability in acute pancreatitis causes the loss of intravenous fluid and reduces plasma volume. In severe cases, in patients with massive ascites, pleural effusion, and retroperitoneal and mesenteric edema, circulating plasma volume decreases markedly. Hypovolemia may lead to shock and acute renal failure, and, because hypovolemic shock may impair the pancreatic microcirculation and promote pancreatic ischemia and necrosis, restoration and maintenance of plasma volume is crucial in severe acute pancreatitis.
2) antibiotics
On the other hand, a placebo-controlled, double-blind trial of ciprofloxacin + metronidazole in patients with predicted severe acute pancreatitis showed that prophylactic administration of these antibiotics did not prevent pancreatic infection (Level 1b).
3)analgesics inj tremadol to relieve pain abdomen)
4) nebulization in view of b/l wheeze
5)diuretics for decreased urine output due to renal failure
Non pharmacological interventions
1)nill per mouth
https://pubmed.ncbi.nlm.nih.gov/27107634/
2)ryles tube catheterisation: to prevent the further inflammation of pancreas
3)oxygenation :As pt is in acidotic breathing and to maintain the saturation
Question 2:
https://aakansharaj.blogspot.com/2020/11/55-year-old-male-with-anemia.html?m=1
1)bone marrow and bones : hypercellilar marror and pancytopenia
2)kidneys : proteinuria
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3205153/
The pathophysiology of renal failure in multiple myeloma is often multifactorial but is mostly due to the high excretion of immunoglobulin free light chains. When the light chains combine with Tamm-Horsfall proteins, they form obstructing casts (5). Chemotherapy should therefore be initiated rapidly to decrease light chain production. Intravenous fluids can be given to treat volume depletion, hypercalcemia, or hyperuricemia.
3)lungs(infection-incrsead susceptibility)
https://www.cancer.org/cancer/multiple-myeloma/causes-risks-prevention/what-causes.html
Plasma cell tumors have important abnormalities in other bone marrow cells and that these abnormalities may also cause excess plasma cell growth. Certain cells in the bone marrow called dendritic cells release a hormone called interleukin-6 (IL-6), which stimulates normal plasma cells to grow. Excessive production of IL-6 by these cells appears to be an important factor in development of plasma cell tumors.
Outcome: Need an oncologist opinion for further management
2) what are pharmacological and non pharmacological interventions given and efficay of each of them?
A) Pharmacological interventions antibiotics (?aytpical pneumonia-azithromycin)
However, the infections encountered in patients with MM include: (1) bacterial infections, predominantly involving respiratory and urinary tract, caused by Streptococcus pneumonia, Staphylococcus aureus, Haemophilus influenzae, Klebsiella pneumonia, Escherichia coli, Pseudomonas aeruginosa, and Enterobacteriaceae; (2) viral infections caused by herpes simplex virus (HSV), VZV, and cytomegalovirus (CMV); (3) fungal infections caused by Candida species and Aspergillus species; and (4) Pneumocystis jiroveci pneumonia
2)Blood transfusion : I/v/0f pancytopenia
B)non pharmacological
Pleural fluid analysis: Exudative picture
imaging -xray skull: Lytic lesions
hrct chest: pleural effusion, consolidatiom
Serum electrophoresis
sputum culture : klebsiella species
Question 3)
http://nithishaavula.blogspot.com/2020/11/51-yr-old-male-with-hfref.html?m=1
a) Where are the different anatomical locations of the patient's problems and what are the different etiologic possibilities for them? Please chart out the sequence of events timeline between the manifestations of each of these problems and current outcomes ?
https://www.cfrjournal.com/articles/Right-Ventricular-Failure
A) Pedal edema with abdominal distension and sob suggestive of right heart failure or renal failure
B)etilogy of rt heart failure
https://www.ncbi.nlm.nih.gov/books/NBK459381/
- Primary pulmonary arterial hypertension (PAH) and secondary pulmonary hypertension (PH) as seen in chronic-obstructive pulmonary disease (COPD) or pulmonary fibrosis)
- Congenital heart disease (pulmonic stenosis, right ventricular outflow tract obstruction, or a systemic RV).
- Valvular insufficiency (tricuspid or pulmonic)
- Congenital heart disease with a shunt (atrial septal defect (ASD) or anomalous pulmonary venous return (APVR)).
- RV ischemia or infarct
- Infiltrative diseases such as amyloidosis or sarcoidosis
- Arrhythmogenic right ventricular dysplasia (ARVD)
- Cardiomyopathy
- Microvascular disease.
- Constrictive pericarditis
- Tricuspid stenosis
- Systemic vasodilatory shock
- Cardiac tamponade
- Superior vena cava syndrome
- Hypovolemia.
A) Pharmacological interventions
https://heart.bmj.com/content/104/5/407(meta analysis with each class of drugs)
Preload reducers
Diuretics should be used only occasionally if pt is symptomatic
Afterload reducers-ace inhibitors
Rate controlling agents-beta blockers
Antiepileptics for known case of epilepsy
Insulin for glycemic control in diabetes.
Non pharmacological interventions
Salt and fluid restriction
https://pubmed.ncbi.nlm.nih.gov/23787719/
Individualized salt and fluid restriction can improve signs and symptoms of CHF with no negative effects on thirst, appetite, or QoL in patients with moderate to severe CHF and previous signs of fluid retention.
Question 4
https://www.healthline.com/health/beriberi#symptoms
Other conditions cause beriberi include:
- Excessive alcohol usage, which results in inadequate intake in the diet as well as prevents the body from absorbing and storing vitamin B1.
- Genetic beriberi, which is an inherited condition where people lose the ability to absorb thiamine from foods. Symptoms usually present during adulthood.
- Pregnancy; pregnant women often present with vitamin B1 deficiency. Breastfeeding infants can suffer from vitamin B1 deficiency if the mother is deficient.
- People with endocrine disorders like hyperthyroidism who require extra vitamin B1.
- Chronic liver disease, which prevents the body from absorbing sufficient vitamin B1.
- Kidney dialysis, which leads to a loss of vitamin B1.
- A prolonged bout of diarrhea, which also to a loss of vitamin B
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851725/
Pharmacological interventions:
Diuretics to decrese the preload
Thiamine to replinish the stores which were lost due to chronic alcoholism
2)non pharmacological interventions
Salt and fluid restriction to decrease the fluid overload
Comments
Post a Comment